Company intelligence / Profile preview

KeyReply

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

KeyReply’s AI platform is commercially deployed in hospitals and clinics across multiple regions. It automates patient interactions and administrative workflows to improve operational efficiency and patient engagement. The system is accredited by Singapore’s Ministry of Health and used by 60% of the country’s public hospitals. No clinical trial results are relevant as it is not a therapeutic product.

Modalities: Non-pharmacological therapy
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Accredited by Singapore's Ministry of HealthPartnerships with leading hospitals/healthcare systems in APAC, Middle East, UK, US regions

Beyond the preview

Go deeper on KeyReply.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KeyReply.

Explore the full profile